Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Published on by Research Hypothesis

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Assoc. Prof. Dr Lucia Ciranna, Università di Catania, Italy

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her groundbreaking research on the serotonin brain system, Fragile X Syndrome, and neurodevelopmental disorders. With a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg (1995) and a Pharmacy degree from the University of Catania (1989), she has significantly advanced understanding of neurological diseases. As an Associate Professor of Physiology at the University of Catania since 2006, she has led innovative studies on neurodevelopment and therapeutic interventions. Her extensive research contributions, spanning over three decades, have earned her prestigious qualifications in France and Italy. Dr. Ciranna’s work has been instrumental in exploring the therapeutic potential of serotonin modulation, glial interactions, and receptor mechanisms in neurological disorders. Her prolific publication record and dedication to advancing neuroscience make her a deserving recipient of the Women Researcher Award. 🧠📚🏅

Publication Profile

Scopus

Education 

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist with a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg, France (1995) 🧠, where she focused on serotonin neurotransmission and neurodevelopment. She earned her Pharmacy degree from the University of Catania (1989) 💊, specializing in neuropharmacology and brain physiology. Her postdoctoral research at the University of Catania (1995-1998) 🔬 explored serotonin’s role in synaptic plasticity and cognition. Further advancing her expertise, she trained in molecular neuroscience and pharmacology (1998-2000) 🎓. Dedicated to lifelong learning, she actively engages in international neuroscience workshops and research collaborations 📖.

Experience

Assoc. Prof. Dr. Lucia Ciranna is a distinguished physiologist at the University of Catania (2006-Present) 🏫, leading groundbreaking research on serotonin’s role in neurological disorders and innovative therapeutic strategies. Previously, she was a researcher at the same institution (1994-2006) 🔬, investigating neurophysiology in cognitive impairments and receptor signaling. She earned her Ph.D. from Louis Pasteur University of Strasbourg (1990-1994) 🎓, focusing on neurodevelopmental mechanisms and serotonin modulation in brain function. Earlier, she contributed to neuropharmacology research at the University of Catania (1989-1990) 🧬. As a scientific collaborator with international neuroscience labs 🌍, she continues exploring cutting-edge advancements in the field.

Awards and Honors

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her contributions to neurophysiology 🧠. She achieved the Qualification to the function of Professeur des Université in France (2012) 🇫🇷 and later became a Professore Ordinario (Full Professor of Physiology) in 2018 🎓. Her research has been supported by prestigious international neuroscience grants 💰, driving innovation in the field. A sought-after speaker, she has delivered distinguished lectures at major neurophysiology conferences worldwide 🎤. Dr. Ciranna’s groundbreaking work on Fragile X Syndrome has earned her accolades for excellence in neurodevelopmental research 🏅.

Presentation

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist specializing in serotonin receptor modulation and its implications for neurodevelopmental disorders 🧠🔬. She has delivered numerous invited seminars and conference presentations worldwide, focusing on the role of 5-HT7 serotonin receptors in synaptic plasticity, cognition, and behavior. Her research explores therapeutic strategies for Fragile X Syndrome and Autism Spectrum Disorders, with key contributions to understanding serotonin-mediated neuromodulation 🎓🧪. Dr. Ciranna has also engaged in public science communication, appearing on RAI Telethon broadcasts 📺. Her work continues to shape novel approaches for treating cognitive disorders through serotonin receptor activation. 🌍📚

Research Focus

Assoc. Prof. Dr. Lucia Ciranna is dedicated to unraveling the complexities of the serotonin brain system 🧠, exploring its role in neurological disorders and potential therapeutic interventions. Her research focuses on Fragile X Syndrome 🧬, aiming to develop targeted treatments for cognitive deficits. She investigates neurodevelopmental disorders 💡, shedding light on autism, intellectual disabilities, and brain dysfunctions. Her work also delves into glial-neuronal interactions 🤝, examining their impact on neurodevelopment and inflammation. Passionate about therapeutic innovations in neuroscience 🏥, she seeks novel drug targets and treatment strategies to improve neurological health and patient outcomes.

Publication Top Notes 

Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells

Editorial: Role of glia in neurodevelopmental disorders

Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer’s Disease

Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Karen Allison, University of Rochester, United States

Assoc. Prof. Dr. Karen Allison is a dedicated ophthalmologist specializing in glaucoma care 👁️‍🗨️. She holds a Doctor of Medicine from Robert Wood Johnson Medical School (1990) 🎓 and an MBA from George Washington University (2013). Currently at the Flaum Eye Institute, she serves as Glaucoma Service Chief and Fellowship Director 👩‍⚕️. With extensive experience in clinical research and education, Dr. Allison has authored impactful studies on glaucoma, disparities in healthcare, and genetic factors in ocular diseases 📚🧬. Her accolades include Leading Physicians in the World and the Women of Distinction honors 🌟. She’s a passionate advocate for diversity and health equity 💙.

Publication Profile

Orcid

Education

Associate Professor Dr. Karen Allison holds a Doctor of Medicine (M.D.) degree from the University of Medicine and Dentistry of New Jersey (Robert Wood Johnson Medical School), earned in May 1990 🩺📚. Further enhancing her expertise, she pursued a Master of Business Administration (M.B.A.) at The George Washington University in Washington, D.C., graduating in January 2013 🎓💼. With a strong foundation in both medicine and business, Dr. Allison combines her clinical acumen and strategic leadership to excel in academia and healthcare management 🌟🌐. Her interdisciplinary background empowers her to contribute meaningfully to education, research, and organizational development. 🌿📖

Certifications and Professional Experience 

Assoc. Prof. Dr. Karen Allison is a board-certified ophthalmologist with extensive expertise in both private practice and academia. 🌟 Her significant contributions at the Flaum Eye Institute include serving as Glaucoma Fellowship Director and Glaucoma Service Chief, showcasing her leadership and dedication to advancing ophthalmic care. 👁️‍🗨️ With a deep commitment to education and innovation in glaucoma management, she bridges clinical excellence with academic rigor. 📚💡 Dr. Allison’s efforts reflect her unwavering passion for improving patient outcomes and mentoring future ophthalmologists, solidifying her reputation as a respected figure in the field of ophthalmology. 🏥🌿

Editorial Roles and Recognition 

Assoc. Prof. Dr. Karen Allison is a leading figure in ophthalmic research and clinical practice 🌟👁️‍🗨️. Her editorial roles in prestigious journals, including the Cureus Journal of Medical Science and the Journal of Medical Case Reports 📚🖋️, underscore her commitment to advancing the field. Through her peer-reviewed publications in high-impact journals 📰📈, Dr. Allison has made significant contributions to the academic community, fostering innovation and knowledge sharing. Her dedication to excellence in research and clinical care continues to inspire professionals and students alike, driving progress in ophthalmology and beyond 🌐🔬.

Awards and Honors 

Assoc. Prof. Dr. Karen Allison is a distinguished ophthalmologist honored with multiple accolades for her contributions to the field and community. She was featured in the Nationwide Registries Women of Distinction Honors Edition in 2021, and recognized as one of the Leading Physicians in the World in 2013. Dr. Allison was named a Top Ophthalmologist in New York in 2013 and 2014. Her dedication to community service earned her awards from the Lions Club of Brooklyn-Kings County in 2013 and the St. Kitts Organization in 2007. 🌟👩‍⚕️🏅🌍

Research Supervision and Mentorship 

Assoc. Prof. Dr. Karen Allison is dedicated to shaping the next generation of researchers. Her commitment shines through her creation of the glaucoma intern research fellowship, which provides invaluable hands-on experience. Beyond that, she has mentored high school students, medical students, and residents, fostering their growth through guidance and supervision of impactful research. This personalized, nurturing approach to education makes her an exceptional academic mentor, helping students thrive in both clinical and research settings. Her passion for teaching and research mentorship is truly inspiring. 🧑‍🏫🔬👩‍🔬💡📚

Research Focus

Assoc. Prof. Dr. Karen Allison’s research primarily focuses on ocular health disparities, particularly glaucoma and age-related macular degeneration (AMD). Her work examines racial, ethnic, and gender disparities in eye care access and treatment, analyzing patterns in gene expression and clinical outcomes across different populations. She evaluates the impact of socioeconomic factors on the utilization of eye care services, leveraging data from sources like the CDC’s Behavioral Risk Factor Surveillance System. Her studies also delve into the genetic underpinnings of eye diseases, seeking to better understand variations in macular tissues and their role in AMD progression. 👁️📊🧬👩‍🔬

Publication Top Notes

Risk factors affecting the utilization of eye care services evaluated by the CDC’s behavior risk factor surveillance system from 2018 to 2021

Uveal effusion syndrome: a case report

Racial and Gender Disparities for Glaucoma Treatment Rates in Upstate New York

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration

Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials A Systematic Review and Meta-analysis

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Mr Alfonso Luca Pendolino, University College London, United Kingdom

Based on Mr. Alfonso Luca Pendolino’s experience and research, he could be considered a strong candidate for the Best Researcher Award. Here’s why:

Publication profile

Scopus

Education

From October 2021, a part-time PhD student at UCL’s Ear Institute focused on olfactory dysfunction in chronic respiratory diseases. Clinical Fellow at the Royal National Throat, Nose & Ear Hospital, London. Delivered oral presentations at ERS Thessaloniki 2021 on nasal septal perforation repair and the triple-layer technique. Earned a diploma in Otorhinolaryngology from the University of Padova with magna cum laude honors. Actively engaged in various courses, including Balloon Sinuplasty in Guildford and Smell and Taste 11 in Dresden. Member of ENT UK and the British Rhinological Society, with scientific habilitation in Italy. ✨👃📚💼

Experience

From October 2023 to October 2024, the user works as a Senior Clinical Fellow at St George’s University Hospital NHS Foundation Trust in Ear, Nose, and Throat Surgery, focusing on rhinology and anterior skull base procedures. From February 2019 to October 2023, they held a similar role at the Royal National Throat, Nose and Ear Hospital, part of University College London Hospitals. Since October 2019, they have also been pursuing a PhD in the Ear Institute at University College London, focusing on research. Previously, from December 2014 to December 2018, they trained as a resident in Otolaryngology at the University of Padova. 🎓🩺📊

Expertise and Contributions

Mr. Pendolino has extensive clinical and academic experience in Ear, Nose, and Throat (ENT) surgery, particularly in rhinology and anterior skull base procedures. His work spans senior clinical fellowships at prestigious institutions like St. George’s University Hospital and the Royal National Throat, Nose, and Ear Hospital, combined with a PhD research focus on olfactory dysfunction at the University College London (UCL). This academic engagement showcases his commitment to advancing medical science, specifically in rhinology.

Notable Research and Publications

He has contributed significantly to academic research, authoring several impactful papers on topics such as nasal septal perforation repair, cocaine-induced destructive lesions, and smell loss related to COVID-19. His recent publications in high-impact journals such as Diagnostics and Laryngoscope address both clinical outcomes and advanced ENT techniques, demonstrating a broad impact on both scientific understanding and patient care.

Continuous Learning and Development

Throughout his career, Mr. Pendolino has pursued a range of certifications and courses, from endoscopic skull base surgery to rhinoplasty, which highlights his dedication to continual professional development. His involvement in international conferences, including oral communications and workshops, further positions him as a leader in his field.

Research Impact

Although many of his papers have limited citations due to their recent publication, his research has already influenced surgical practices and patient outcomes, especially concerning sinus surgery and chronic respiratory disease management.

conclusion

Mr. Pendolino’s combination of clinical expertise, high-quality research, and ongoing contributions to ENT surgery make him a commendable candidate for the Best Researcher Award.

Publication top notes

Objective and Subjective Outcomes Following Radiofrequency of Inferior Turbinates in Patients with Sleep-Disordered Breathing

The role of ANCA in the management of cocaine-induced midline destructive lesions or ENT pseudo-granulomatosis with polyangiitis: a London multicentre case series

Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy

Clinical factors influencing olfactory performance in patients with persistent COVID-19 smell loss longer than 1 year

The role of large cavity sinus surgery in the management of chronic rhinosinusitis in non-steroidal anti-inflammatory drug exacerbated respiratory disease: A single-centre experience and long-term outcomes

Reply to: Letter to the editor regarding “Long-term quality-of-life impairment in patients with more than 1-year COVID-19–related olfactory dysfunction”